tradingkey.logo
搜索

Fortrea Holdings Inc

FTRE
添加自选
13.660USD
-0.580-4.07%
收盘 05/15, 16:00美东报价延迟15分钟
1.29B总市值
亏损市盈率 TTM

Fortrea Holdings Inc

13.660
-0.580-4.07%

关于 Fortrea Holdings Inc 公司

Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.

Fortrea Holdings Inc简介

公司代码FTRE
公司名称Fortrea Holdings Inc
上市日期Jun 16, 2023
CEOThakrala (Anshul)
员工数量15500
证券类型Ordinary Share
年结日Jun 16
公司地址8 Moore Drive
城市DURHAM
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编27709
电话18774950816
网址https://www.fortrea.com/
公司代码FTRE
上市日期Jun 16, 2023
CEOThakrala (Anshul)

Fortrea Holdings Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
--
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
52.45K
+74.00%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
52.45K
+74.00%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
48.36K
+80.27%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
46.10K
+84.20%
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mark Morais
Mr. Mark Morais
Chief Operating Officer and President - Clinical Services
Chief Operating Officer and President - Clinical Services
--
--
Ms. Hima B. Inguva
Ms. Hima B. Inguva
Investor Relations
Investor Relations
--
--
Ms. Erin L. Russell
Ms. Erin L. Russell
Independent Director
Independent Director
--
--
Mr. Anshul Thakrala
Mr. Anshul Thakrala
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
--
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
52.45K
+74.00%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
52.45K
+74.00%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
48.36K
+80.27%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
46.10K
+84.20%
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--

收入明细

单位: USD更新时间: 4月6日 周一
单位: USD更新时间: 4月6日 周一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2021
FY2020
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
North America
1.29B
47.35%
Europe
851.70M
31.27%
Other
582.10M
21.37%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 5月10日 周日
更新时间: 5月10日 周日
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.95%
Goldman Sachs & Company, Inc.
8.39%
Corvex Management LP
4.77%
State Street Investment Management (US)
4.35%
Vanguard Capital Management, LLC
4.27%
其他
64.27%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.95%
Goldman Sachs & Company, Inc.
8.39%
Corvex Management LP
4.77%
State Street Investment Management (US)
4.35%
Vanguard Capital Management, LLC
4.27%
其他
64.27%
股东类型
持股股东
占比
Investment Advisor
45.75%
Hedge Fund
22.47%
Investment Advisor/Hedge Fund
20.28%
Research Firm
12.48%
Pension Fund
1.58%
Bank and Trust
1.55%
Individual Investor
0.61%
Family Office
0.34%
Holding Company
0.05%

机构持股

更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
881
98.32M
103.93%
-25.18M
2025Q4
861
101.77M
121.97%
--
2025Q3
941
101.78M
123.79%
-128.81K
2025Q2
971
101.91M
125.96%
+8.10M
2025Q1
934
96.29M
123.92%
-15.90M
2024Q4
888
96.88M
127.14%
-3.71M
2024Q3
843
100.39M
126.92%
-3.95M
2024Q2
819
103.77M
114.37%
+7.39M
2024Q1
774
92.63M
104.75%
-1.02M
2023Q4
713
91.56M
111.23%
-6.24M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
13.20M
14.12%
+528.42K
+4.17%
Dec 31, 2025
Goldman Sachs & Company, Inc.
7.94M
8.49%
+48.14K
+0.61%
Dec 31, 2025
Corvex Management LP
4.51M
4.82%
--
--
Dec 31, 2025
State Street Investment Management (US)
4.11M
4.4%
+39.78K
+0.98%
Dec 31, 2025
Sessa Capital
3.99M
4.27%
--
--
Dec 31, 2025
Charles Schwab Investment Management, Inc.
3.22M
3.44%
+565.89K
+21.33%
Dec 31, 2025
AQR Capital Management, LLC
2.99M
3.2%
-747.42K
-20.01%
Dec 31, 2025
Fidelity Management & Research Company LLC
2.57M
2.75%
-395.60K
-13.34%
Dec 31, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Brandes US Small-Mid Cap Value ETF
1.39%
Invesco S&P Spin-Off ETF
0.97%
Invesco S&P SmallCap Health Care ETF
0.58%
Invesco S&P SmallCap 600 Revenue ETF
0.25%
Invesco S&P SmallCap 600 Pure Value ETF
0.23%
Schwab Fundamental U.S. Small Company ETF
0.17%
iShares S&P Small-Cap 600 Value ETF
0.16%
Humankind US Stock ETF
0.14%
ProShares Ultra Nasdaq Biotechnology
0.14%
State Street SPDR S&P 600 Small Cap Value ETF
0.13%
查看更多
Brandes US Small-Mid Cap Value ETF
占比1.39%
Invesco S&P Spin-Off ETF
占比0.97%
Invesco S&P SmallCap Health Care ETF
占比0.58%
Invesco S&P SmallCap 600 Revenue ETF
占比0.25%
Invesco S&P SmallCap 600 Pure Value ETF
占比0.23%
Schwab Fundamental U.S. Small Company ETF
占比0.17%
iShares S&P Small-Cap 600 Value ETF
占比0.16%
Humankind US Stock ETF
占比0.14%
ProShares Ultra Nasdaq Biotechnology
占比0.14%
State Street SPDR S&P 600 Small Cap Value ETF
占比0.13%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI